First Time Loading...

CKD Bio Corp
KRX:063160

Watchlist Manager
CKD Bio Corp Logo
CKD Bio Corp
KRX:063160
Watchlist
Price: 24 000 KRW Market Closed
Updated: May 10, 2024

Wall Street
Price Targets

Price Targets Summary
CKD Bio Corp

Wall Street analysts forecast CKD Bio Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CKD Bio Corp is 27 000 KRW .

Lowest
Price Target
Not Available
Average
Price Target
27 000 KRW
13% Upside
Highest
Price Target
Not Available
CKD Bio Corp Competitors:
Price Targets
300110
Huaren Pharmaceutical Co Ltd
301% Upside
214370
Caregen Co Ltd
139% Upside
TARO
Taro Pharmaceutical Industries Ltd
3% Upside
LQDA
Liquidia Corp
105% Upside
DMP
Dermapharm Holding SE
56% Upside
VRCA
Verrica Pharmaceuticals Inc
69% Upside
PPLPHARMA
Piramal Pharma Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
CKD Bio Corp

For the last 8 years the compound annual growth rate for CKD Bio Corp's revenue is 5%. The projected CAGR for the next 1 year is 10%.

5%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CKD Bio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CKD Bio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CKD Bio Corp's stock price target?
Price Target
27 000 KRW

According to Wall Street analysts, the average 1-year price target for CKD Bio Corp is 27 000 KRW .

What is CKD Bio Corp's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for CKD Bio Corp's revenue is 5%. The projected CAGR for the next 1 year is 10%.